We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

DiaSys Acquires Intersep

By HospiMedica staff writers
Posted on 17 Oct 2000
DiaSys Corp. (New York, NY, USA) has acquired Intersep Limited, a UK-based manufacturer of consumable laboratory products, reagents, and test kits. DiaSys designs, manufactures, and distributes medical laboratory equipment. Intersep will become a wholly owned subsidiary of DiaSys, which will consolidate all European manufacturing, sales, and service operations under the new subsidiary's managing director, Paul Reardon.

Todd M. DeMatteo, president and CEO of DiaSys, stated that the company acquired Intersep because of the tremendous product and market synergies between the two firms. He said that Intersep's consumable products and reagents are like "blades” for the "razors” of DiaSys. DeMatteo also noted that Intersep has a strong European presence, a network of distributors, and several key European certifications, all of which are indispensable to DiaSys' strategic growth plan.

"DiaSys is a good acquisition partner because it is well-organized and has a very sound strategic growth plan,” said Intersep's Reardon. He stated that the combination of the companies not only furthers the objectives of DiaSys' growth plan but also creates a distribution platform for numerous additional products and system-selling strategies.

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
ESR Analyzer
TEST1 2.0

Latest Industry News

WHX Labs Dubai to Gather Global Experts in Antimicrobial Resistance at Inaugural AMR Leaders’ Summit
17 Oct 2000  |   Industry

BD and Penn Institute Collaborate to Advance Immunotherapy through Flow Cytometry
17 Oct 2000  |   Industry

Abbott Acquires Cancer-Screening Company Exact Sciences
17 Oct 2000  |   Industry